Medical nutrition is also referred as clinical nutrition. It means the nutrition required for the management of patients, including not only outpatients at clinics, but also inpatients in hospitals. It includes primarily the SCIENTIFIC fields of nutrition and dietetics. Furthermore, medical nutrition therapy is a specialized, dietician-developed regimen used to treat chronic illness or other medical condition.
The Vietnam medical nutrition market is expected to register substantial growth in the near future, owing to rise in incidence of chronic diseases and surge in geriatric population across Vietnam. However, lack of awareness of nutrition problems among Vietnamese is projected to hamper the market growth during the forecast period. Conversely, a rise in medical tourism in Vietnam is expected to offer remunerative opportunities for market players.
The Vietnam medical nutrition market is segmented on the basis of product, application, distribution channel, and end user. By product, the market is categorized into infant nutrition, parenteral nutrition, and enteral nutrition. The parenteral nutrition is further segmented into dextrose based products, fat based products, and additives based products. The enteral nutrition is further segmented into standardized, semi elemental, and specialized. By application, the market is categorized into diabetes, cancer, gastrointestinal diseases, chronic kidney disease, chronic liver disease, intensive care, chronic obstructive pulmonary disease, and others. By distribution channel, the market is classified into hospital pharmacies, drug store & retail pharmacies, and online pharmacies. By end user, the market is segmented into private hospitals, public hospitals, and homecare.
Key Benefits for Stakeholders
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
- An in-depth analysis of country is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate country-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the Vietnam medical nutrition market is provided.
Key Market Segments
- By Product
- Infant Nutrition
- Parenteral Nutrition
- Dextrose-based Products
- Fat-based Products
- Additives-based Products
- Enteral Nutrition
- Standardized
- Semi Elemental
- Specialized
- By Application
- Diabetes
- Cancer
- Gastrointestinal Diseases
- Chronic Kidney Disease
- Chronic Liver Disease
- Intensive Care
- Chronic Obstructive Pulmonary Disease
- Others
- By Distribution Channel
- Hospital Pharmacies
- Drug Store & Retail Pharmacies
- Online Pharmacies
- By End User
- Private Hospitals
- Public Hospitals
- Homecare
Key Market Players
- Abbott Laboratories
- Baxter International Inc.
- B. Braun Melsungen AG.
- Fresenius SE & Co. KGaA.
The other players in the value chain include (profiles not included in the report):
- Danone Nutricia
- Mead Johnson Nutrition Co.
- Nestle S.A.
- Bayer AG
- Pfizer Inc.
- Sanofi S.A.
- GlaxoSmithKline Plc
- Perrigo Company Plc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
